FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Bionpharma Doxylamine Succinate and Pyridoxine HCl Recall

Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count…

Bionpharma Inc. · Princeton, NJ

Risk level
Class III
Reported by FDA
Sep 9, 2026
Recall ID
D-0822-2026
Check your lot numberHow we source this data

Summary

Bionpharma recalled Doxylamine Succinate and Pyridoxine HCl starting Aug 7, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0822-2026 on Sep 9, 2026. Reason: Presence of Foreign Tablets/Capsules. Status: Ongoing.

Why it was recalled

Presence of Foreign Tablets/Capsules

Product description

Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.

Lot numbers, UPCs & expiration codes

Lot # DMA25006, Exp Date: 11/30/2028.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0822-2026
Classification
Class III
Status
Ongoing
Recall initiated
Aug 7, 2026
FDA report date
Sep 9, 2026
Quantity
14,232 bottles (1,423,200 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
Bionpharma Inc.

Original FDA data

Every field from FDA enforcement report D-0822-2026, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
99551
Address
400 Alexander Park Ste 2-4b
Code information
Lot # DMA25006, Exp Date: 11/30/2028.
Postal code
08540-6539
Report date
Sep 9, 2026
Product type
Drugs
Recall number
D-0822-2026
Classification
Class III
Recalling firm
Bionpharma Inc.
Product quantity
14,232 bottles (1,423,200 tablets)
Reason for recall
Presence of Foreign Tablets/Capsules
Voluntary / mandated
Voluntary: Firm initiated
Product description
Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.
Distribution pattern
US Nationwide.
Recall initiation date
Aug 7, 2026
Initial firm notification
Letter
Center classification date
Aug 28, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0822-2026, published Sep 9, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls